6 assets in Acute Megakaryoblastic Leukemia

Therapeutic assets addressing Acute Megakaryoblastic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Acute Megakaryoblastic Leukemia	Fred Hutchinson Cancer Center	P3	BBB (74)
Fludarabine Acute Megakaryoblastic Leukemia	Fred Hutchinson Cancer Center	P3	BB (70)
Vorinostat Acute Megakaryoblastic Leukemia	National Cancer Institute (NCI)	P2	BB (65)
Azacitidine Acute Megakaryoblastic Leukemia	University of Chicago	P1/2	B (59)
Thiotepa Acute Megakaryoblastic Leukemia	Fred Hutchinson Cancer Center	P2	CCC (53)
Dilanubicel Acute Megakaryoblastic Leukemia	Fred Hutchinson Cancer Center	P2	CCC (50)